This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Ajinomoto Co., Ltd.. Active years: 2016-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2024
Title: Yohei Miyagi: Innovator in Pancreatic and Prostatic Disease Evaluation
Introduction
Yohei Miyagi is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of medical diagnostics, particularly in evaluating pancreatic and prostatic diseases. With a total of 2 patents, his work is paving the way for advancements in cancer evaluation methods.
Latest Patents
Miyagi's latest patents include a method for evaluating pancreatic cancer and a method for evaluating prostatic disease. The pancreatic cancer evaluation method involves obtaining amino acid concentration data from blood samples of subjects. This data is then used to calculate a value based on a previously established formula, which helps in assessing the state of pancreatic cancer. The method incorporates concentration values of various amino acids, including Asn, His, Thr, and others, to provide a comprehensive evaluation.
The method for evaluating prostatic disease similarly relies on amino acid concentration data. It measures the concentration values of specific amino acids in blood samples to evaluate conditions such as prostatic cancer and prostatic hypertrophy. This innovative approach highlights the importance of amino acid profiles in diagnosing and understanding these diseases.
Career Highlights
Yohei Miyagi is associated with Ajinomoto Co., Ltd., a company known for its focus on food products and biotechnology. His work at Ajinomoto has allowed him to explore the intersection of nutrition and health, leading to groundbreaking inventions in disease evaluation.
Collaborations
Miyagi has collaborated with notable colleagues, including Takahiko Muramatsu and Naoyuki Okamoto. These partnerships have fostered a collaborative environment that enhances the research and development of innovative diagnostic methods.
Conclusion
In summary, Yohei Miyagi is a key figure in the field of medical diagnostics, with a focus on pancreatic and prostatic disease evaluation. His innovative methods and collaborations are contributing to significant advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile